Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 323.20M | $ 374.50M | $ 787.50M | $ 403.70M | $ 361.90M |
Total Assets | $ 2.88B | $ 2.95B | $ 2.47B | $ 2.08B | $ 1.88B |
Total Debt | $ 976.60M | $ 1.00B | $ 983.20M | $ 724.50M | $ 703.10M |
Net Debt | $ 653.40M | $ 629.10M | $ 195.70M | $ 320.80M | $ 341.20M |
Total Liabilities | $ 1.96B | $ 2.18B | $ 1.76B | $ 1.48B | $ 1.35B |
Stockholders Equity | $ 918.80M | $ 773.30M | $ 699.30M | $ 596.30M | $ 521.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |